Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia

Ottmann, Oliver G. ORCID: https://orcid.org/0000-0001-9559-1330, Müller-Tidow, Carsten, Krämer, Alwin, Schlenk, Richard F., Lübbert, Michael, Bug, Gesine, Krug, Utz, Bochtler, Tilmann, Voss, Florian, Taube, Tillmann, Liu, Dan, Garin-Chesa, Pilar and Döhner, Hartmut 2019. Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia. British Journal of Haematology 184 (6) , pp. 1018-1021. 10.1111/bjh.15204

[thumbnail of OTTMANN, Oliver - Phase I dose-escalation trial investi.pdf]
Preview
PDF - Accepted Post-Print Version
Download (484kB) | Preview
Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Wiley
ISSN: 0007-1048
Date of First Compliant Deposit: 3 June 2019
Date of Acceptance: 3 June 2018
Last Modified: 07 Nov 2023 04:45
URI: https://orca.cardiff.ac.uk/id/eprint/123126

Citation Data

Cited 21 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics